Phase II Study of Recombinant Interferon Alpha and Etoposide in Patients With Relapsed Osteosarcoma.

Trial Profile

Phase II Study of Recombinant Interferon Alpha and Etoposide in Patients With Relapsed Osteosarcoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2012

At a glance

  • Drugs Etoposide; Interferon alpha
  • Indications Osteosarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 May 2009 Actual end date (1 Mar 2009) and additional lead trial centre added as reported by ClinicalTrials.gov record.
    • 27 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 14 Jan 2008 The expected completion date for this trial is now 1 Nov 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top